SGLT2 inhibitors may help reduce the risk of nephrolithiasis in patients with type 2 diabetes, including those with co-existing gout. Recent large-scale studies support that sodium-glucose ...

It is necessary to revolutionise diabetes care beyond just medical prescriptions from doctors but also mental health care ...

Some school districts, including MSCS, have what's called a self-funded health plan. That means the employer pays for ...

GLP-1 agonist drugs like Ozempic, and SLGT2 inhibitor drugs like Jardiance have been linked with a lower risk of a second ...

Eli Lilly's tirzepatide cut the risk of developing type 2 diabetes for people with pre-diabetes by 94%, according to new ...

There are three types of diabetes: type 1 (usually childhood onset), type 2 (usually adult onset), and gestational (during ...

On World Diabetes Day, it's worth taking a look back at the last 10.5 months in the diabetes technology space.

With the rising popularity of telehealth providers offering GLP-1 medications like Ozempic, the terminology can get confusing ...

News and talk of GLP-1 drugs are everywhere these days—from their smash success in treating Type 2 diabetes and obesity to their astronomical pricing, drug shortages, compounding disputes ...

Earlier, he had discovered that another class of drugs against diabetes-2, the so-called SGLT2 inhibitors also appeared to work well for patients with chronic kidney damage without diabetes.

Dr Ambrish Mithal, Chairman & Head, Endocrinology & Diabetes, Max Super Speciality Hospital, Saket, said that Ozempic belongs to a class of drugs called GLP-1 agonist, which means they act through the ...